Why the study?
Does a prolonged QTc interval increase the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease?
Cohort (n=6,565)
Yes
Does a prolonged QTc interval increase the risk of all-cause and cardiovascular mortality in patients with chronic kidney disease?
Prolonged QTc interval is independently associated with increased all-cause and cardiovascular mortality in patients with chronic kidney disease, and adding QTc to CKD significantly improves mortality risk prediction.
Objective Prolonged QT interval predisposes to ventricular arrhythmias and sudden cardiac death. However, the association between QT interval and mortality by the level of pre-existing kidney function has not been investigated. Methods We followed 6565 participants from the National Health and Nutrition Examination Survey III for a median of 13.3 years. Sample divided according to corrected QT (QTc) interval was as follows: normal (QTc <450 ms for men and <460 ms for women) or prolonged. It was further categorised as follows: (1) no chronic kidney disease (CKD), that is, albumin to creatinine ratio (ACR) <30 mg/g and estimated glomerular filtration rate (eGFR) > 60 mL/min/1.73 m2 ; (2) CKD by eGFR only (eGFR <60 mL/min/1.73 m2, ACR <30 mg/g); (3) CKD by ACR only (ACR >30 mg/g, eGFR >60 mL/min/1.73 m2) and (4) CKD by both. Cox proportional hazards models were used. Results CKD group had prolonged QTc than those without CKD (20.5%vs12.9%, p<0.0001). Both prolonged QTc and CKD are independently associated with increased risk of mortality. When combined, risk of mortality is higher in those with CKD by eGFR with prolonged QTc than normal QTc (HR 2.6 (1.7–3.9) and 3.1 (1.7–5.4) vs 1.4 (1.1–1.7) and 1.7 (1.3–2.1) for all-cause and CV mortality). There is no significant difference in risk in those with CKD by ACR when QTc is prolonged. There is significant improvement in risk prediction for all-cause and CV mortality when QTc is added to CKD beyond established CV risk factors (net reclassification index p<0.00001). Conclusion A screening ECG in those with CKD may help in finer risk stratification and may be considered.
No takes yet. Share an insight, caveat, or question.
Malik et al. (2017) conducted a cohort in Chronic kidney disease (n=6,565). Prolonged QTc interval vs. Normal QTc interval was evaluated on All-cause mortality (HR 2.6, 95% CI 1.7-3.9).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: